Skip to main content Skip to main menu
UF Health University of Florida
Pediatric Pulmonary Division Department of Pediatrics in the College of Medicine
Carmen Leon Astudillo

Carmen Leon Astudillo, M.D.

Associate Professor

Department: MD-PEDS-PULMONARY
Business Phone: (352) 273-8381
Business Email: cleonastudillo@ufl.edu

On This Page

About Carmen Leon Astudillo

Carmen Leon Astudillo, MD, is a board-certified pediatric pulmonologist. She received her medical degree from Universidad del Azuay, in Ecuador. After completing her pediatric residency at Cincinnati Children’s Hospital Medical Center, she trained in Pediatric Pulmonology at Boston Children’s Hospital. Dr. Leon Astudillo joined the University of Florida as a clinical assistant professor in 2018. Her clinical and research duties focus mainly on patients with neuromuscular and rare diseases, in particular those with spinal muscular atrophy and Duchenne muscular dystrophy. Dr Leon Astudillo is also part of the aerodigestive program at the University of Florida.

Board Certifications

  • Pediatric Pulmonology
    American Board of Pediatrics
  • Pediatrics
    American Board of Pediatrics

Clinical Profile

Specialties

  • Pediatrics

Subspecialties

  • Pediatric Neuromuscular
  • Pediatric Pulmonary

Areas of Interest

  • Asthma
  • Asthma in Children
  • Duchenne Muscular Dystrophy
  • Friedreich Ataxia
  • Myotonia Congenita
  • Pompe Disease
  • Spinal Muscular Atrophy

Publications

Academic Articles

Grants

  1. A PHASE IV OPEN-LABEL STUDY EVALUATING THE EFFECTIVENESS AND SAFETY OF RISDIPLAM ADMINISTERED IN PEDIATRIC PATIENTS WITH SPINAL MUSCULAR ATROPHY WHO EXPERIENCED A PLATEAU OR DECLINE IN FUNCTION AFTER GENE THERAPY

    Active

    Role:
    Principal Investigator
    Funding:
    GENENTECH INC

  2. A PHASE IV OPEN-LABEL STUDY EVALUATING THE EFFECTIVENESS AND SAFETY OF RISDIPLAM ADMINISTERED AS AN EARLY INTERVENTION IN PEDIATRIC PATIENTS WITH SPINAL MUSCULAR ATROPHY AFTER GENE THERAPY

    Active

    Role:
    Principal Investigator
    Funding:
    GENENTECH INC

  3. A Phase 3, Multi national, Long-Term Follow-Up Study to Evaluate Safety and Efficacy in Subjects Who Have Previously Received SRP-9001 in a Clinical Study

    Active

    Role:
    Principal Investigator
    Funding:
    SAREPTA THERAPEUTICS

  4. Swallowing Degradation in Untreated Natural History Patients with Spinal Muscular Atrophy Type 1: Establishing an International Registry of Bulbar Dysfunction

    Role:
    Principal Investigator
    Funding:
    UNIV OF MINNESOTA via GENENTECH INC

  5. A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of SRP-9001 in Non-Ambulatory and Ambulatory Subjects With Duchenne Muscular Dystrophy (ENVISION)

    Active

    Role:
    Principal Investigator
    Funding:
    SAREPTA THERAPEUTICS

  6. A Phase 3 Multinational, Randomized, Double-Blind, Placebo-Controlled Systemic Gene Delivery Study to Evaluate the Safety and Efficacy of SRP-9001 in Subjects with Duchenne Muscular Dystrophy (EMBARK)

    Active

    Role:
    Principal Investigator
    Funding:
    SAREPTA THERAPEUTICS

  7. CTOA

    Active

    Role:
    Principal Investigator
    Funding:
    UNIV OF FLORIDA

  8. Earl and Christy Powell University Chair in Gene Therapy and Genetics Research – F017885/6

    Role:
    Project Manager
    Funding:
    UF FOUNDATION

Education

  1. Fellowship – Pediatric Pulmonology

    Boston Children’s Hospital

  2. Residency – Pediatrics

    Cincinnati Children’s Hospital Medical Center

  3. M.D.

    Universidad del Azuay

Contact Details

Phones:
Business:
(352) 273-8381
Emails:
Business:
cleonastudillo@ufl.edu
Addresses:
Business Mailing:
1600 SW ARCHER RD
PEDIATRIC – PULMONARY DIVISION
 GAINESVILLE FL 32610
Business Street:
HD-506
1600 SW ARCHER RD
 Gainesville FL 32610